Study Design of a Brazilian Observational Study of Edoxaban in Patients with Atrial Fibrillation (EdoBRA).
Dalton Bertolim PrecomaRafael Paletta da SilvaAllyson NakamotoViviane Mariz OmarDanilo LopesJosé Francisco Kerr SaraivaPublished in: Arquivos brasileiros de cardiologia (2024)
EdoBRA observational study will generate relevant additional information about NOAC Edoxaban on various aspects of patient management in routine care, such as its safety and effectiveness profile in patients with NVAF in Brazil.